Matches in SemOpenAlex for { <https://semopenalex.org/work/W2262404983> ?p ?o ?g. }
Showing items 1 to 97 of
97
with 100 items per page.
- W2262404983 endingPage "AB13" @default.
- W2262404983 startingPage "AB13" @default.
- W2262404983 abstract "Allergic bronchopulmonary aspergillosis (ABPA) is a complex respiratory disease with significant morbidity and mortality. ABPA occurs in 10% of patients with severe asthma. Patients usually demonstrate positive skin prick test to Aspergillus, decline in lung function, elevated total IgE levels, elevated Aspergillus fumigatus specific IgE antibody, and central bronchiectasis. Symptoms are often persistent despite conventional asthma therapy. Serious adverse effects from long-term use of high dose inhaled and oral corticosteroids include immunosuppression, adrenal insufficiency, osteoporosis, and many others. Antifungals are also problematic due to drug interactions and monitoring requirements. Some studies suggest that omalizumab may be a better therapeutic option as there is some evidence demonstrating efficacy in ABPA and fewer adverse effects than long-term corticosteroids. A retrospective chart review was performed on ABPA patients receiving omalizumab from 2007-2015 at our tertiary care Allergy & Asthma Clinic and The Ottawa Hospital Chest Clinic. Data was collected on demographics, skin prick testing, inhaled /oral corticosteroid use, asthma exacerbations/hospitalizations and quality of life (QoL). Ten patients were evaluated (59.7±13.9 years, 7 females, 3 males). By month 16, the average dose of inhaled corticosteroids dropped by 24%.There was an 89% drop in prednisone intake from baseline in three oral-steroid dependent patients. Nine subjects reported exacerbations 12 months prior to treatment, but none reported exacerbations once they started omalizumab. QoL scores improved from baseline. Our retrospective study provides compelling evidence that supports the hypothesis that omalizumab may be an effective low-risk treatment for ABPA patients, a much underserved patient population." @default.
- W2262404983 created "2016-06-24" @default.
- W2262404983 creator A5001190973 @default.
- W2262404983 creator A5013514320 @default.
- W2262404983 creator A5013807033 @default.
- W2262404983 creator A5015221678 @default.
- W2262404983 creator A5020446882 @default.
- W2262404983 creator A5021711017 @default.
- W2262404983 creator A5037223159 @default.
- W2262404983 creator A5041266745 @default.
- W2262404983 creator A5049108371 @default.
- W2262404983 creator A5060850749 @default.
- W2262404983 creator A5065435030 @default.
- W2262404983 creator A5066097370 @default.
- W2262404983 creator A5069704127 @default.
- W2262404983 creator A5074737631 @default.
- W2262404983 creator A5082387653 @default.
- W2262404983 creator A5084000193 @default.
- W2262404983 creator A5086506641 @default.
- W2262404983 date "2016-02-01" @default.
- W2262404983 modified "2023-09-27" @default.
- W2262404983 title "Omalizumab Can be Effective in Patients with Allergic Bronchopulmonary Aspergillosis" @default.
- W2262404983 doi "https://doi.org/10.1016/j.jaci.2015.12.042" @default.
- W2262404983 hasPublicationYear "2016" @default.
- W2262404983 type Work @default.
- W2262404983 sameAs 2262404983 @default.
- W2262404983 citedByCount "0" @default.
- W2262404983 crossrefType "journal-article" @default.
- W2262404983 hasAuthorship W2262404983A5001190973 @default.
- W2262404983 hasAuthorship W2262404983A5013514320 @default.
- W2262404983 hasAuthorship W2262404983A5013807033 @default.
- W2262404983 hasAuthorship W2262404983A5015221678 @default.
- W2262404983 hasAuthorship W2262404983A5020446882 @default.
- W2262404983 hasAuthorship W2262404983A5021711017 @default.
- W2262404983 hasAuthorship W2262404983A5037223159 @default.
- W2262404983 hasAuthorship W2262404983A5041266745 @default.
- W2262404983 hasAuthorship W2262404983A5049108371 @default.
- W2262404983 hasAuthorship W2262404983A5060850749 @default.
- W2262404983 hasAuthorship W2262404983A5065435030 @default.
- W2262404983 hasAuthorship W2262404983A5066097370 @default.
- W2262404983 hasAuthorship W2262404983A5069704127 @default.
- W2262404983 hasAuthorship W2262404983A5074737631 @default.
- W2262404983 hasAuthorship W2262404983A5082387653 @default.
- W2262404983 hasAuthorship W2262404983A5084000193 @default.
- W2262404983 hasAuthorship W2262404983A5086506641 @default.
- W2262404983 hasBestOaLocation W22624049831 @default.
- W2262404983 hasConcept C126322002 @default.
- W2262404983 hasConcept C141105273 @default.
- W2262404983 hasConcept C159654299 @default.
- W2262404983 hasConcept C167135981 @default.
- W2262404983 hasConcept C177713679 @default.
- W2262404983 hasConcept C187212893 @default.
- W2262404983 hasConcept C197934379 @default.
- W2262404983 hasConcept C203014093 @default.
- W2262404983 hasConcept C2776042228 @default.
- W2262404983 hasConcept C2778564945 @default.
- W2262404983 hasConcept C2778720950 @default.
- W2262404983 hasConcept C2778871687 @default.
- W2262404983 hasConcept C2908647359 @default.
- W2262404983 hasConcept C71924100 @default.
- W2262404983 hasConcept C99454951 @default.
- W2262404983 hasConceptScore W2262404983C126322002 @default.
- W2262404983 hasConceptScore W2262404983C141105273 @default.
- W2262404983 hasConceptScore W2262404983C159654299 @default.
- W2262404983 hasConceptScore W2262404983C167135981 @default.
- W2262404983 hasConceptScore W2262404983C177713679 @default.
- W2262404983 hasConceptScore W2262404983C187212893 @default.
- W2262404983 hasConceptScore W2262404983C197934379 @default.
- W2262404983 hasConceptScore W2262404983C203014093 @default.
- W2262404983 hasConceptScore W2262404983C2776042228 @default.
- W2262404983 hasConceptScore W2262404983C2778564945 @default.
- W2262404983 hasConceptScore W2262404983C2778720950 @default.
- W2262404983 hasConceptScore W2262404983C2778871687 @default.
- W2262404983 hasConceptScore W2262404983C2908647359 @default.
- W2262404983 hasConceptScore W2262404983C71924100 @default.
- W2262404983 hasConceptScore W2262404983C99454951 @default.
- W2262404983 hasIssue "2" @default.
- W2262404983 hasLocation W22624049831 @default.
- W2262404983 hasOpenAccess W2262404983 @default.
- W2262404983 hasPrimaryLocation W22624049831 @default.
- W2262404983 hasRelatedWork W1553814522 @default.
- W2262404983 hasRelatedWork W1897018659 @default.
- W2262404983 hasRelatedWork W2094666519 @default.
- W2262404983 hasRelatedWork W2564940999 @default.
- W2262404983 hasRelatedWork W2989891361 @default.
- W2262404983 hasRelatedWork W3096827963 @default.
- W2262404983 hasRelatedWork W3164286735 @default.
- W2262404983 hasRelatedWork W4224227857 @default.
- W2262404983 hasRelatedWork W4244365749 @default.
- W2262404983 hasRelatedWork W4307029761 @default.
- W2262404983 hasVolume "137" @default.
- W2262404983 isParatext "false" @default.
- W2262404983 isRetracted "false" @default.
- W2262404983 magId "2262404983" @default.
- W2262404983 workType "article" @default.